We also found increased expression of stem cell markers, including OCT4, Lin28, KLF, Bmi-1, CD44 and SOX2, in colon cancer cells upon treatment with BM-MSCs-derived exosomes (Fig. 3d). Here, CD44 is linked to malignant colon neoplasm.